(Alliance News) - AstraZeneca PLC on Friday announced that datopotamab deruxtecan has shown "encouraging and durable efficacy" in phase 1 trials. Read More
(Alliance News) - AstraZeneca PLC on Thursday releases results from trials on its breast cancer drugs camizestrant and capivasertib, both when compared to faslodex, which treats breast cancer. Read More
(Alliance News) - Stocks in London closed in the red on Wednesday, despite a strong performance from pharmaceutical stocks, as investors digested a raft of economic data from both China and Europe. Read More
(Alliance News) - AstraZeneca PLC on Wednesday said its Enhertu drug achieved statistically significant overall survival in breast cancer patients in a recent trial. Read More
(Alliance News) - Stocks in Europe were mostly in the red on Wednesday, as economic data from China stoked fear of a global slowdown, while the FTSE 100 was spared a steeper decline thanks to gains by pharmaceutical stocks. Read More
(Alliance News) - Stock prices in London mostly opened flat on Wednesday, with falls in FTSE 100 housebuilders, miners and oil majors offset by gains for pharmaceuticals as GSK shook off Zantac litigation. Read More
(Alliance News) - AstraZeneca PLC on Wednesday announced the sale of its West Chester manufacturing site in the US state of Ohio to National Resilience Inc. Read More
(Alliance News) - AstraZeneca PLC said it agreed to buy Neogene Therapeutics Inc for the treatment of cancer, as also noted by healthcare company Syncona Ltd on Tuesday. Read More
(Alliance News) - The FSTE 100 opened in the green on Tuesday as investors were reassured that civil unrest in China would be short lived amid unyielding action by the authorities. Read More
(Alliance News) - C4X Discovery Holdings PLC on Monday said it signed an exclusive worldwide licensing agreement with AstraZeneca PLC for its NRF2 Activator programme. Read More
(Alliance News) - AstraZeneca PLC on Monday said in won three recommendations for approval for the treatment of adults with cancers in the European Union from the Committee for Medicinal Products for Human Use of the European Medicines Agency. Read More
(Alliance News) - Stocks in London were mostly lower on Monday, though the FTSE 100 was in the green as investors looked ahead to the UK budget statement later in the week, which Chancellor Jeremy Hunt promised to be "rabbit-free". Read More
(Alliance News) - AstraZeneca PLC on Friday said the US Food & Drug Administration has approved its cancer drugs Imfinzi and Imjudo in combination with chemotherapy for the treatment of adults with stage four non-small cell lung cancer. Read More
(Alliance News) - AstraZeneca PLC on Thursday said it was continuing to see the benefit of sustained investment, as it raised its annual guidance on the back of strong results in the year to date. Read More
(Alliance News) - Stocks in Europe struggled early on Thursday, though the FTSE 100 notched a minor gain, as investors held their breath ahead of all-important inflation data from the world's largest economy. Read More
(Alliance News) - Stocks in London are called lower on Thursday, with a stack of UK corporate updates keeping investors busy until the afternoon's eagerly-anticipated US inflation reading. Read More
